Successful fertility outcome in a couple with recurrent implantation failure and testicular cancer survivor: A case report

Partha Sarathi Das


A couple of Indo-American descent, presented to our clinic with a history of primary infertility and repeated IVF implantation failure. Male was a testicular cancer survivor who had erectile dysfunction and azoospermia. Female partner had polycystic ovarian syndrome (PCOD). She had three unsuccessful attempts of embryo transfer at another fertility clinic. At our clinic, she underwent controlled ovarian stimulation, COH started from day two period with rFSH (follicle stimulating hormone) followed by HMG (human menopausal gondadotropin) with antagonist protocol followed by preimplantation genetic screening of embryos. Subsequently, she began HRT (hormone replacement Therapy) protocol for ERA cycle from day 2, where she also underwent hysteroscopy on day 7.  After five days of progesterone supplementation, she underwent endometrial biopsy for ERA (endometrial receptivity assay). Frozen embryo transfer cycle was started with the same HRT protocol used in her previous ERA cycle. Post embryo transfer, immunotherapy with steroids and fortnightly intralipids was given. Pregnancy test was positive with a BHCG value of 290 mIU/mL. and she delivered naturally after 39 completed weeks of gestation. A stepwise personalized treatment approach maximizes the chances of a successful outcome in presence of both male and female factors. Frozen or fresh sperms for ICSI with PGS along with hysteroscopy, ERA and under cover of immune modulation yielded positive results. (Afr J Reprod Health 2021; 25[3]: 130-134).

Full Text:



Simon A and Laufer N. Assessment and treatment of

repeated implantation failure (RIF). J Assist Reprod Genet. 2012;29(11):1227–39. doi: 10.1007/s10815-012-9861-4.

Tan BK, Vandekerckhove P, Kennedy R and Keay SD.

Investigation and current management of recurrent IVF treatment failure in the UK. BJOG An Int J Obstet Gynaecol. 2005;112(6):773–80. doi: 10.1111/j.1471-0528.2005.00523.x.

Pishgar F, Haj-Mirzaian A, Ebrahimi H, Saeedi

Moghaddam S, Mohajer B, Nowroozi MR, et al. Global, regional and national burden of testicular cancer, 1990–2016: results from the Global Burden of Disease Study 2016. BJU Int. 2019;124(3):386–94. doi: 10.1111/bju.14771.

Auger J, Sermondade N, Eustache F. Semen quality of

young cancer and systemic disease patients: Baseline data and clinical considerations. Basic Clin Androl. 2016;26(1)3. doi: 10.1186/s12610-016-0031-x.

Rives N, Perdrix A, Hennebicq S, SaïAs-Magnan J, Melin

MC, Berthaut I, et al. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: Results of the French National CECOS Network. J Androl. 2012;33(6):1394–401. doi: 10.2164/jandrol.112.016592.

Nazareth I, Lewin J and King M. Sexual dysfunction after

treatment for testicular cancer: A systematic review. J Psychosom Res. 2001;51(6):735–43. doi: 10.1016/s0022-3999(01)00282-3.

Thompson-Cree MEM, McClure N, Donnelly ET, Steele

KE and Lewis SEM. Effects of cryopreservation on testicular sperm nuclear DNA fragmentation and its relationship with assisted conception outcome following ICSI with testicular spermatozoa. Reprod Biomed Online. 2003;7(4):449–55. doi: 10.1016/s1472-6483(10)61889-5.

Ping P, Gu BH, Li P, Huang YR and Li Z. Fertility

outcome of patients with testicular tumor: Before and after treatment. Asian J Androl. 2014;16(1):107–11. doi: 10.4103/1008-682X.122194.

Al-Turki HA. Hysteroscopy as an investigation tool in

recurrent implantation failure in vitro fertilization. Saudi Med J. 2018;39(3):243–6. doi: 10.15537/smj.2018.3.21379.

Pabuçcu EG, Yalçın İ, Bodur T, Çağlar GS and Pabuçcu

R. Impact of office hysteroscopy in repeated implantation failure: Experience of a single center. J Turkish Ger Gynecol Assoc. 2016;17(4):197–200. doi: 10.5152/jtgga.2016.16166.

El-Toukhy T, Sunkara SK, Coomarasamy A, Grace J and

Khalaf Y. Outpatient hysteroscopy and subsequent IVF cycle outcome: A systematic review and meta-analysis. Reprod Biomed Online. 2008;16(5):712–9. doi: 10.1016/s1472-6483(10)60486-5.

Mahajan N. Endometrial receptivity array: Clinical

application. J Hum Reprod Sci. 2015;8(3):121–9. doi: 10.4103/0974-1208.165153.

Moreno I, Codoñer FM, Vilella F, Valbuena Di, Martinez-

Blanch JF, Jimenez-Almazán J, et al. Evidence That the Endometrial Microbiota Has an Effect on Implantation Success or Failure. Obstet Gynecol Surv. 2017;72(6):341–2. doi: 10.1016/j.ajog.2016.09.075.

Singh M, Chaudhry P and Asselin E. Bridging endometrial

receptivity and implantation: Network of hormones, cytokines, and growth factors. J Endocrinol. 2011;210(1):5–14. doi: 10.1530/JOE-10-0461.


  • There are currently no refbacks.